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http:WHAT THIS PAPER ADDS?
Measuring great saphenous vein (GSV) diameter is standard in pre-interventional assessment of varicose
disorders, but has never been properly validated. This work assessed the relative value of measuring GSV
diameter at the most often used sites: the sapheno-femoral junction and the proximal thigh. We found a better
correlation of the latter with reﬂux and both higher sensitivity and speciﬁcity for clinical disease severity. A
conversion factor was calculated and used to revise published data. The conversion factor enabled comparison
of venous disease severity of patients included in 10 interventional series with preoperative GSV measurements
taken either at the sapheno-femoral junction or at the proximal thigh.Background: Great saphenous vein (GSV) incompetence is involved in the majority of cases of varicose disease.
Standardised pre-interventional assessment is required to analyse the relative merit of treatment modalities. We
weighed GSV diameter measurement at the sapheno-femoral junction (SFJ) against measurement at the proximal
thigh 15 cm distal to the groin (PT), established a conversion factor and applied it to selected literature data.
Methods: Legs with untreated isolated GSV reﬂux and varices limited to its territory and control legs were
studied clinically, with duplex ultrasound and photoplethysmography. GSV diameters were measured at both the
SFJ and the PT. A conversion factor was calculated and used to compare published data.
Results: Of 182 legs, 60 had no GSV reﬂux (controls; group I), 51 had above-knee GSV reﬂux only (group II) and 71
had GSV reﬂux above and below knee (group III). GSV diameters in group I measured 7.5 mm (1.8) at the SFJ
and 3.7 mm (0.9) at the PT. In groups II and III, they measured 10.9 mm (3.9) at the SFJ and 6.3 mm (1.9) at
the PT (p < 0.001 each). Measurement at the PT revealed higher sensitivity and speciﬁcity to predict reﬂux and
clinical class. Good correlation between sites of measurement (r ¼ 0.77) allowed a conversion factor (SFJ ¼ 1.767
* PT, PT ¼ 0.566*SFJ) to be applied to pre-interventional data of published studies.
Conclusions: GSV diameter correlates with clinical class, measurement at the PT being more sensitive and more
speciﬁc than measurement at the SFJ. Applying the conversion factor to published data suggests that some
studies included patients with minor disease.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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an impact on morbidity, quality of life and health costs. The
great saphenous vein (GSV) is involved in the majority of
cases. Symptoms include distressing feelings of swelling and
heaviness and frank pain. Objective ﬁndings are meandering
and dilated superﬁcial veins, oedema, dermatitis, dermato-
sclerosis and skin ulceration. These manifestations are the
consequence of long-standing volume overload andresponding author. E. Mendoza, Speckenstrasse 10, 31515 Wunstorf,
ny. Tel.: þ49 5031 912781; fax: þ49 5031 912782.
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//dx.doi.org/10.1016/j.ejvs.2012.10.014hypertension in cutaneous veins caused by wall distension,
valve incompetence, blood ﬂow abnormality and secondary
phenomena such as allergy and inﬂammation.
Treatment is directed towards abolition of venous reﬂux.
For decades, this has been accomplished by ligation of the
GSV at its junction with the common femoral vein (CFV) and
vein stripping, ﬁrst of the entire GSV, later limited to its
reﬂuxing part. In the last decades, alternative options
became available, such as haemodynamic surgery,2e5
endovenous thermal ablation6e8 and foam sclerotherapy.9
Duplex ultrasound is widely employed to guide these
interventions.
Comparison of treatment modalities requires exact
documentation of the clinical, anatomical and functional
situation prior to whichever treatment is given.10,11 Reﬂux
E. Mendoza et al. 77and GSV diameter measurements may serve as surrogate
parameters for disease severity and provide criteria for
planning interventions and monitoring outcome. GSV
diameters have been assessed at various sites with different
techniques: upright or recumbent patient position, cross-
sectional or longitudinal imaging, and various sites of
interest. Measurements are regularly made at the sapheno-
femoral junction (SFJ), above or below the pre-terminal
valve, and anywhere at the thigh. A consensus-based
manual recommends two sites where GSV diameters should
be measured, 3 cm below the SFJ and mid-thigh,10 while
earlier studies used a site 15 cm below the SFJ.12,13 Thus far,
neither the clinical relevance of these measurements nor
the relative signiﬁcance of the site of measurement has
been clariﬁed.
The aim of this study was to investigate a possible
correlation of GSV diameters measured at the SFJ and the
proximal thigh (PT) with the importance of the venous
disorder and to establish a conversion factor usable to
compare published data.
METHODS
An anatomical and functional survey of the GSV was
undertaken in consecutive outpatients who consulted with
the suspicion or presence of a primary venous disorder. It
was a practitioner-initiated study performed in a vein clinic
in Germany between October and December 2009. The
protocol was accepted by the Ethics Committee of the State
Medical Chamber of Lower Saxony, Germany.
The criterion for patient inclusion was the presence of
a leg with isolated GSV reﬂux and varices limited to its
territory. Eligible legs were included irrespective of the
ﬁndings on the other leg. Exclusion criteria were previous
treatment of the index leg for varicose veins and its
complications, deep venous reﬂux, acute disorders
(thrombosis, phlebitis and cellulitis) and lymphoedema.
Candidates with known pregnancy, age below 18 years and
any concomitant overt health problem were excluded.
Colour-coded duplex ultrasound examinations were per-
formed by a single investigator with a General Electric Logic
5 colour-coded duplex scanner ﬁtted with a 7.5-MHz linear
probe.10,14 The GSV was examined in the standing position
applying toe movements, manual compression and
decompression as well as Valsalva manoeuvres to assess
orthograde ﬂow and reﬂux. Reﬂux lasting longer than 1 s
was considered pathologic.15
The detailed anatomical and functional ultrasound study
was the basis for selection and sorting of legs. Included were
legs with GSV reﬂux beginning at the terminal or the pre-
terminal valve and escaping through a mid-thigh branch vein
(GSV incompetence above knee only e group II (As2)) or
escaping through a lower leg branch vein (GSV incompetence
above and below knee e group III (As2,3)). No assessment
was made of dilated distal branch veins and eventually
incompetent perforator veins. Excluded were legs with reﬂux
through the terminal and pre-terminal valve escaping
through the anterior or the posterior accessory veins with
competent valves in the GSV just distal to the groin. Furtherwere excluded legs with no reﬂux in the GSV trunk at the PT
but with reﬂux in the distal portion, as seen in cases with
incompetence of thigh perforators, reﬂux from the short
saphenous vein through a Giacomini anastomosis or incom-
petence of superﬁcial branches joining the GSV at mid thigh.
Legs with no GSV reﬂux but meeting the other inclusion and
exclusion criteria were recruited as controls (group I).
Clinical ﬁndings were documented according to the
highest CEAP (Clinical, etiologic, anatomic and pathophysi-
ologic) class. Legs could range from teleangiectasies (C1) to
healed venous ulcers (C5). In all cases, the aetiology was
primary (Ep) and pathophysiology reﬂux (Pr). The anatomy
was varicose GSV trunk with (As23þ5) or without (A2þ3)
branch varices. Findings in control legs could be C0, C0s, C1,
C2 (Ep, As5 and Pr) and C3.
Vein diameters were measured holding the probe trans-
versely with no pressure. Duplicate measurements were
taken at two sites: at the SFJ distal to the terminal valve and
15 cm below the junction. This site, chosen by CHIVA
(Conservative ambulatory haemodynamic management of
VAricose veins) Group members, shows parallel walls of the
GSV and is located above the junction of the most proximal
branch veins.12,13
Photoplethysmography was performed with the ELCAT
Vasoquant instrument. Muscle pump activity is described
as blanching of the skin, in %. Reﬁlling time to 100% is given
in seconds.
Power analysis was based on data of an unpublished pilot
study, which revealed a Pearson’s r ¼ 0.8 for the compar-
ison of GSV diameters measured simultaneously at the SFJ
and PT. In this study, we intended to differentiate between
three groups. Power analysis asked for inclusion of 46
participants per group to discriminate between Pearson’s r
of 0.7 and 0.9 with a statistical power of 80%. Therefore,
a study was set up with 60 consecutive patients per group.
Subject allocation was planned to be halted when 60
control legs and 120 legs of groups II and III were included.
Data analysis was performed with Statistical Package for
the Social Sciences (SPSS) 13.0. To compare subgroups, chi-
squared tests for non-parametric and t-tests or Analysis of
Variance (ANOVA) for parametric data were applied. Pear-
son correlations were calculated to compare vein diameters
with other parameters. A p < 0.05 was considered signiﬁ-
cant. Speciﬁcity and sensitivity were calculated taking the
diameter values of subjects without reﬂux as threshold
values (mean, meanþ1SD and mean þ 2SD). The discrimi-
nating power of diameters measured at the SFJ and the PT
for reﬂux and C-classes 2e5 was estimated by calculating
Area Under the Receiver Operating Characteristic (AUROC)
curves and 95% conﬁdence intervals (CIs).
A conversion factor was established, which allowed
comparison of the vein diameter measured at the SFJ with
the diameter determined at the PT. A Pearson’s r  0.7 was
considered to be high enough to permit the use of a linear
regression model without entering a constant and to
calculate a conversion factor between the two variables
(diameter SFJ ¼ b1 * diameter PT and diameter PT ¼ b2 *
diameter SFJ with b1 ¼ 1/b2).
Figure 1. Study ﬂow chart
78 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 1 January/2013The conversion factor was applied to published data.
Selection of studies was begun with a systematic literature
search in Medline, gathering studies on the treatment of
GSV insufﬁciency with stripping, endoluminal ablation by
laser or radiofrequency, foam sclerotherapy, CHIVA or
incompetent sAphenouS Vein preservAtion with phLebec-
tomy (ASVAL) published between 2000 and 2010. Eligible
studies had to state inclusion and exclusion criteria
similar to the ones used in this survey and to provide
pre-interventional data on reﬂux and GSV diameters
measured at the SFJ or at the PT in a standing position.
Studies applying diameter limits for inclusion were
excluded. Studies that presented pre-interventional data on
various occasions were included only once. Authors wereTable 1. Patient characteristics and venous disease classiﬁcation.
Entire cohort GSV reﬂux absent
Group I, As015
N or mean % or SD N or mean % or
N (legs) 182 60
Female 116 64% 35 58%
Age 56 15 56 15
Height 170 9 172 9
Weight 82 20 83 20
BMI 28.3 6.1 27.8 6.3
C0 29 16% 27 45%
C1 28 15% 13 22%
C2 63 35% 7 12%
C3 44 24% 13 22%
C4a 12 7% 0 e
C4b 5 3% 0 e
C5 1 1% 0 e
Venous pump function (%) 4.0 2.4 3.6 2.5
Reﬁlling time (sec) 26 12 29 13
a Group II > III; p ¼ 0.031.
b Group II > III; p ¼ 0.023.
c Group I > II þ III; p ¼ 0.009.contacted for clariﬁcation if this was not clear from the
publication. The factor was used to mutually convert data
obtained at either point in order to make the studies
comparable.
RESULTS
We screened 844 legs and included 182 legs in the survey
(Fig. 1). Sixty legs with no GSV reﬂux and no exclusion
criteria served as controls (group I, As0  1  5, Pr). Truncal
GSV reﬂux was found in 122 legs. Reﬂux was limited to the
thigh in 51 legs (above knee reﬂux, group II, As, Pr2  5) and
extended to the lower leg in 71 legs (above and below knee
reﬂux, group III, As2 þ 3  5, Pr).
Demography of patients was equal in the three groups
with the exception of weight and body mass index (BMI),
which was slightly higher in patients of group II compared
to group III (Table 1).
Clinical ﬁndings of a venous disorder were absent (C0) in
45% of patients in group I. Teleangiectases (C1) were found in
22%, branch varices (C2) in 12% and oedema (C3) in 22%, the
latter associated with branch varices and/or obesity and lip-
oedema. In groups II and III, absence of any sign of a venous
disorder (C0) was found in 3% and teleangiectasis only (C1)
was observed in 12%. Branch varices (C2) were found in 46%,
oedema (C3) in 25% and skin changes (C4e5) in 15%.
Venous function tests were normal in legs with no GSV
reﬂux (group I): muscle pump function 3.6% (2.5) and
reﬁlling time 29.0 s (13.0). In patients with GSV reﬂux
(groups II and III), muscle pump function was normal
(4.1  2.4%). Reﬁlling time was slightly shortened to 23.9 s
(11.6) as compared with group I (p < 0.05).
GSV diameters in all groups, measured at both sites, were
not related with patients’ age and sex or calf muscle-pump
function. Modest correlations were found with body weight
in each group (Pearson’s r ¼ 0.30e0.44, p < 0.01) and BMI
(Pearson’s r ¼ 0.25e0.38, p < 0.01) but not with height.GSV reﬂux present Differences
Group II, As25 Group III, As2þ35
SD N or mean % or SD N or mean % or SD X2 or F P
51 71
33 65% 48 68% 1.24 0.538
56 13.5 55 15 0.59 0.943
170 9.9 169 9 2.12 0.123
87 21.0 79 18 2.37 0.097a
30.0 6.8 27.5 5 2.92 0.057b
0 e 2 3% 75.08 <0.001
6 12% 9 13%
25 49% 31 44%
12 24% 19 27%
5 10% 7 10%
3 6% 2 3%
0 e 1 1%
4.0 2.2 4.2 2.5 0.82 0.440
23 10 25 12 4.00 0.020c
Conversion PT to SFJ (95%CI 1.6981.836):diameter SFJ
(mm) ¼ 1.767  diameter PT (mm)
Conversion SFJ to PT (95% CI 0.5440.588):diameter
PT (mm) ¼ 0.566  diameter SFJ (mm)
E. Mendoza et al. 79Signiﬁcant correlations were found with clinical disease
classes for the whole sample (Pearson’s r ¼ 0.46e0.54;
p < 0.001) and for legs with reﬂux alone (Pearson’s
r ¼ 0.39e0.42, p < 0.001). GSV diameter and reﬁlling time
correlated with reﬂux (Pearson’s r ¼ 0.25e0.28, p < 0.01).
GSV diameters in controls (group I) measured 7.5 mm
(1.8) at the SFJ and 3.7 mm (0.9) at the PT (Table 2). In
patients with GSV reﬂux (groups II and III), they measured
10.9 mm (3.9) at the SFJ and 6.3 mm (1.9) at the PT,
respectively. Vein diameters were larger in the presence of
reﬂux, compared with its absence, by an average of 3.4 mm
at the SFJ (p < 0.001) and 2.6 mm at the PT (p < 0.001). No
difference in diameters was found between group II
(10.5 mm  3.2 at the SFJ and 6.2 mm  1.7 at the PT) and
group III (11.2 mm  4.3 at the SFJ and 5.9 mm  2.1 at the
PT, see Table 2). Thus, the degree of vein dilatation was
independent of the length of reﬂux above knee only versus
above and below knee.
GSV diameters were assessed with regard to their value
to predict reﬂux and clinical disease class (Table 3 and
Fig. 2). The proportion of vein diameters smaller than the
mean values of group I patients and of those positioned
above the 2 SD margins were calculated.
A GSV diameter above the 2 SD margin of group I legs
was found in 2% in group I at either point of measurement.
In groups II and III, a signiﬁcantly different prevalence was
observed when measurements made at the SFJ and PT,
respectively. The 2 SD margin was exceeded by 43% of
patients when measured at the SFJ and by 62% when
measured at the PT. Sensitivity and speciﬁcity are calculated
for thresholds at the mean, 1 SD and 2 SD above the mean
diameters of the control group.
Clinical disease class was also better predicted by diam-
eter assessment at the PT than the SFJ level. Of legs with
C0e1, 2% exceeded the 2 SD margins at the SFJ and 4% at
the PT. Of legs with C2e5, 49% exceeded the limit when
diameters were measured at the SFJ and 59% when
measured at the PT.
AUROC curves were used to assess the relative perfor-
mance of the two sites of measurement (Fig. 3). The areas
under the curve for the prediction of GSV reﬂux were
signiﬁcantly larger when measured at the PT (SFJ:
AUROC ¼ 0.786, 95% CI ¼ 0.064; femoral AUROC ¼ 0.907,
95% CI ¼ 0.041). The difference was not signiﬁcant for the
prediction of C-class 2e5 (SFJ: AUROC ¼ 0.782, 95%
CI ¼ 0.065; femoral AUROC ¼ 0.839, 95% CI ¼ 0.056).Table 2. GSV diameters measured at the SFJ and PT as a function of
N SFJ diam
Group I (no GSV reﬂux) 60 7.5 mm
Groups II & III (GSV reﬂux) 122 10.9 mm
Difference between groups I and II & III T ¼ 6.4
p < 0.0
Group II (thigh reﬂux only) 51 10.5 mm
Group III (lower leg reﬂux) 71 11.2 mm
Difference between groups II and III T ¼ 0.9
p ¼ 0.3A GSV diameter of <7.5 mm at the SFJ was associated
with reﬂux in 20%, C2e5 disease in 21% and the combined
elements in 15%, respectively. A PT diameter of <3.7 mm
was associated with reﬂux in 3%, C2e5 disease in 9% and the
combined elements in 2%.
Based on linear regression analysis, a mathematical
formula was developed to mutually convert measurements
taken at the SFJ and the PT. The correlation factors were
Pearson’s r ¼ 0.44 for legs in group I and r ¼ 0.77 for legs in
groups II and III. Thus, we limited calculations to groups II
and III. The formulae are shown in the frame.The conversion factors were applied to published data
(Table 4). The literature search had identiﬁed 32 studies
providing pre-treatment data on GSV diameters assessed in
patients evaluated for the treatment of varicose disease of
the GSV. Eight publications, including 1.856 patients, ful-
ﬁlled our predeﬁned requirements. Two trials presented
a single patient group and six trials compared surgical
techniques with two patient groups, which allowed evalu-
ating 14 cohorts. In six trials (10 cohorts) including 1268
patients diameters were measured at the SFJ16e21. In two
studies (four cohorts) including 588 patients measurements
were taken at the PT.12,13 As compared with our patients
with reﬂux, average GSV diameters were smaller in eight
and larger in six cohorts. In six cohorts, the average diam-
eter was below the 1SD margin of our patients with reﬂux
and in one cohort it was in the range of our control
population.DISCUSSION
Comparison of treatment modalities requires exact docu-
mentation of the clinical, anatomical and functional situa-
tion in each patient using standardised and validated
techniques. However, even the recommendations of the
Union Internationale de Phlébologie (UIP)10 regarding
measurement of GSV diameter at different sites lack proper
validation. Until now no effort was undertaken to show if
different measurement points correlate with each otherthe presence and extent of reﬂux.
eter PT diameter Pearson r P
 1.8 3.7 mm  0.9 0.44 <0.001
 3.9 6.3 mm  1.9 0.77 <0.001
01
T ¼ 9.9
p < 0.001
 3.2 6.2 mm  1.7 0.81 <0.001
 4.3 6.3 mm  2.1 0.75 <0.001
47
T ¼ 0.5
p ¼ 0.593
Table 3. Sensitivity and speciﬁcity for reﬂux and clinical disease class of sites of diameter measurement. Percentage of diameters below and above mean, mean þ 1SD, and mean þ 2SD of the
GSV diameters measured at the SFJ and PT in group I. Speciﬁcity and sensitivity between the absence (group I) and presence of reﬂux (group II & III legs), and no or minor (C0-1) and
important (C2-5) venous disease.
GSV reﬂux Diameter at SFJ Diameter at PT
No (n ¼ 60) Yes (n ¼ 122) Speciﬁcity Sensitivity Predicted correctly No (n ¼ 60) Yes (n ¼ 122) Speciﬁcity Sensitivity Predicted correctly
Meana Below 50.0% 19.7% 0.556 0.766 0.703 51.7% 3.3% 0.886 0.803 0.819
Above 50.0% 80.3% 48.3% 96.7%
Meanb þ 1SD Below 85.0% 39.3% 0.515 0.892 0.687 81.7% 19.7% 0.671 0.899 0.808
Above 15.0% 60.7% 18.3% 80.3%
Meanc þ 2SD Below 98.3% 57.4% 0.457 0.981 0.610 98.3% 38.5% 0.557 0.987 0.736
Above 1.7% 42.6% 1.7% 61.5%
CEAP C 0e1 (n ¼ 57) 2e5 (n ¼ 125) 0e1 (n ¼ 57) 2e5 (n ¼ 125)
Meana Below 49.1% 20.8% 0.519 0.773 0.698 42.1% 8.8% 0.686 0.776 0.758
Above 50.9% 79.2% 57.9% 91.2%
Meanb þ 1SD Below 86.0% 40.0% 0.495 0.904 0.681 73.7% 24.8% 0.575 0.862 0.747
Above 14.0% 60.0% 26.3% 75.2%
Meanc þ 2SD Below 98.2% 58.4% 0.434 0.981 0.593 96.5% 40.8% 0.519 0.974 0.709
Above 1.8% 41.6% 3.5% 59.2%
a Mean diameter of the control group (SFJ 7.54 mm, PT 3.66 mm).
b Mean diameter þ 1 SD of the control group (SFJ 9.36 mm, PT 4.58 mm).
c Mean diameter þ 2SD of the control group (SFJ 11.18 mm, PT 5.50 mm).
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Figure 2. GSV diameters (mm) measured at the SFJ (Panels A and C) and the PT (Panels B and D) as related to the presence of reﬂux (Panels
A and C) and clinical class (Panels B and D). Data were gathered from healthy controls and patients with above and above and below knee
reﬂux. The reference lines denote the mean 2 SD of values found in controls.
E. Mendoza et al. 81and whether one or the other site allows better prediction
of the clinical situation.
We took measurements at the SFJ as proposed by the UIP
and compared it with measurements at the PT as used andFigure 3. Area under the receiver operator characteristic (AUROC) curv
SFJ and PT, respectively with regard to the presence of GSV reﬂux (Papublished by the CHIVA group because no data on the mid-
thigh point have been published until 2010.
Diameter measurement at the PT seems to have some
advantages as compared with measurement at the SFJ,es to ascertain the accuracy of GSV diameter measurement at the
nel A) and C-classes 2e5 (Panel B) by.
Table 4. Literature derived pre-interventional GSV diameters measured at one of the sites studied in this survey and converted to the other
site. Data are sorted according to diameter size; calculated data are in italics.
Author treatment investigated N Site of measurement SFJ diameter Direction of conversion PT diameter
Pittaluga, P ASVAL16 303 SFJ 7.1  0.2 / 4.0  0.4
Gonzalez-Zeh Foam17 53 SFJ 7.6  3.0 / 4.3  1.7
Theivacoumar LASER18 84 SFJ 7.7  2.0 / 4.4  1.1
Theivacoumar LASER18 27 SFJ 7.9  1.6 / 4.5  0.9
Gonzalez-Zeh LASER17 45 SFJ 8.2  3.2 / 4.6  1.8
Pittaluga, P HLS16 270 SFJ 8.4  0.3 / 4.8  0.5
Creton Closure Fast19 295 SFJ 8.4  2.3 / 4.8  1.3
Pannier LASER20 85 SFJ 10.0  0.4 / 5.7  0.2
This study 122 SFJ & PT 10.9  3.9 )/ 6.3  1.9
Parés Stripping12 167 PT 11.5  1.1 ) 6.5  1.9
Cappelli CHIVA13 177 PT 11.7  1.0 ) 6.7  1.7
Doganci LASER21 54 SFJ 11.8  4.1 ) 6.7  7.3
Parés CHIVA12 167 PT 12.0  1.1 ) 6.8  2.0
Doganci LASER21 52 SFJ 12.1  4.3 ) 6.8  7.6
Cappelli CHIVA13 77 PT 12.4  1.1 ) 7.1  2.0
82 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 1 January/2013which is a landmark easily identiﬁed with ultrasound. While
GSV reﬂux in the groin is readily identiﬁed measurement of
vein diameter right there is challenging for several reasons.
The curvature of the inguinal GSV renders adjustment of the
ultrasound probe exactly perpendicular to the vein axis
difﬁcult. Further, the shape of the vein is inﬂuenced by
joining epigastric, pudendal and accessory veins and even-
tual aneurysmatic dilatations caused by deep venous
reﬂuxes. Thus, diameter assessment in the groin appears
less reliable.
The PT site 15 cm below the SFJ is located in the truncal
portion of GSV where the vein is cylindrical and largely
devoid of joining branches. The site is also well accessible
and diameter measurements can be taken reliably.
In our experience, nearly a third of patients with reﬂux in
GSV limited to above knee have a sufﬁcient GSV at mid
thigh, because the reﬂuxing branch has left the GSV more
proximally. Thus, the diameter of the reﬂuxing part of the
GSV would be missed if measurements were taken at mid
thigh.
The CHIVA Group measures diameters 15 cm distal to the
SFJ12,13 because the PT site allows outcome assessment, as
their treatment strategy leaves the GSV trunk in situ even
when crossectomy is performed.
A further advantage emerges from our data. Measure-
ment at the PT as compared to measurement at the SFJ
demonstrated higher accuracy and both higher sensitivity
and speciﬁcity for venous disease class as well as for
prediction of reﬂux (Table 3). Thus, diameter measurement
at the PT may develop as a surrogate parameter for speciﬁc
clinical situations.
Ourdata revealed a debatableﬁnding: GSVdiameter, venous
haemodynamics (reﬁlling times in photoplethysmography
(PPG)) and clinical disease class did not differ whether reﬂux
was above knee only or above and below knee.The ﬁnding is in
disagreement with the understanding that the length of reﬂux
in the GSV would have an inﬂuence on disease severity.18,22,23
The correlation between the two measurement sites
permitted calculation of a conversion factor used to reviewselected publications. It disclosed a wide range of diameters
in patients worked up for interventions with different
techniques (Table 4). The data suggest that some studies
included patients with minor disease. The same may be true
for a recent study that found no correlation between GSV
diameter and quality of life.24 The reported diameters were
within the limits of the control subjects of this study.
Diameter assessment at the PT seems suitable for strat-
iﬁcation of patients allocated to future interventional trials
as well as for outcome evaluation. With more data available
it may also become an argument in the discussion of
treatment options with patients, which is not the case at
the moment.
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